D Battelli

Department of Anesthesia and Pain Medicine, San Marino Hospital, San Marino, San Marino.

14 publications 1989 – 2018

What does D Battelli research?

D Battelli studies how commonly used medications, such as painkillers, ulcer medications, and blood clot prevention drugs, affect the health of older adults, particularly regarding organ damage. They have specifically looked into how these medications impact the digestive system, heart, and kidneys in elderly patients. The goal of their research is to understand the risks involved in using these drugs together and to help doctors make safer choices when prescribing medications for older individuals.

Key findings

  • NSAIDs (painkillers) increase the risk of kidney problems in older adults.
  • Using antithrombotic drugs (blood clot preventers) raises the risk of kidney damage by 82%.
  • Ulcer medications decrease the risk of stomach damage but are still linked to a 37% increased risk of kidney problems.

Frequently asked questions

Does Dr. Battelli study the effects of painkillers?
Yes, Dr. Battelli researches how painkillers like NSAIDs affect kidney health in older adults.
What conditions does Dr. Battelli's research focus on?
Their research mainly focuses on organ damage related to the digestive system, heart, and kidneys in elderly patients.
Is Dr. Battelli's work relevant to elderly patients on multiple medications?
Yes, their work is crucial for developing safer medication combinations for elderly patients who may be more vulnerable to organ damage.

Publications in plain English

A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review.

2018

Pain and therapy

Varrassi G, Fusco M, Skaper SD, Battelli D, Zis P +3 more

Plain English
This research paper looks at how the immune cells called mast cells and microglia contribute to problems with chronic pain and the use of opioids, which are powerful pain-relief medications. The findings reveal that using opioids can lead to increased pain sensitivity and reduced effectiveness of the drugs over time, due to the activation of these immune cells. This matters because it highlights the need for new treatments to prevent these side effects and improve the way opioids are used for pain management. Who this helps: This helps patients suffering from chronic pain who rely on opioids for relief.

PubMed

Thoracic Paravertebral Analgesia Through a New Multiple-Hole Catheter.

2016

Journal of cardiothoracic and vascular anesthesia

Zani G, Bizzarri FT, Maitan S, Fusari M, Battelli D +2 more

PubMed

Current pain education within undergraduate medical studies across Europe: Advancing the Provision of Pain Education and Learning (APPEAL) study.

2015

BMJ open

Briggs EV, Battelli D, Gordon D, Kopf A, Ribeiro S +2 more

Plain English
The APPEAL study looked at how pain education is taught in medical schools across Europe to see if it meets the needs of future doctors. It found that only 31% of schools offered a dedicated pain course, with most teaching pain within general courses, and 7% of schools had no pain education at all. On average, students spent only 12 hours learning about pain, which is not enough given how common pain is as a health issue. Who this helps: This helps medical students and ultimately patients by improving how doctors understand and treat pain.

PubMed

Analgesic, antiulcer, antithrombotic drugs and organ damage: a population-based case-control study.

2015

Minerva medica

Battelli D, Riccardi R, Piscaglia AC, Stefanelli ML, Mussoni L +3 more

Plain English
This study looked at how commonly painkillers (NSAIDs), ulcer medications (AUDs), and blood clot preventers (ATDs) are used by older people with organ damage to the digestive system, heart, or kidneys. It found that while ulcer medications seemed to lower the risk of stomach damage, NSAIDs and ATDs increased the risk of kidney problems. Specifically, using ATDs raised the risk of kidney damage by 82% and using AUDs increased it by 37%. This matters because it highlights the risks of combining these common medications in elderly patients who are already vulnerable to organ damage. Who this helps: This research helps doctors prescribe safer medication combinations for elderly patients.

PubMed

A clinical evaluation of the pediatric i-gel™ for airway management during MRI examination.

2014

Journal of anaesthesiology, clinical pharmacology

Corso RM, Battelli D, Maitan S, Zampone S, Agnoletti V

PubMed

Intrathecal therapy with ziconotide: clinical experience and considerations on its use.

2008

Minerva anestesiologica

Vitale V, Battelli D, Gasperoni E, Monachese N

Plain English
The study focused on ziconotide, a new drug used for treating severe chronic pain by blocking certain channels in the spinal cord. It showed a significant ability to relieve pain for patients who had not found success with other treatments, offering effective pain relief in many cases. While there were some side effects, they were fewer than those associated with morphine, which often leads to addiction and other complications. Who this helps: This benefits patients suffering from severe chronic pain, especially those who have not responded to other treatments.

PubMed

Effects of dehydroepiandrosterone and carnitine treatment on rat liver.

1994

Biochemistry and molecular biology international

Battelli D, Bellei M, Kneer N, Contri MB, Ronchetti IP +2 more

Plain English
This study investigated how two treatments, dehydroepiandrosterone (DHEA) and L-carnitine, affect liver function in rats. The researchers found that while DHEA boosts the metabolism of fatty acids in the liver, taking L-carnitine alongside it significantly reduces the positive effects DHEA has on liver enzymes and changes its structure. However, L-carnitine did not affect the weight loss that DHEA caused in the rats. Who this helps: This research benefits scientists and doctors looking to understand liver metabolism and how treatments interact.

PubMed

Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone.

1993

Journal of bioenergetics and biomembranes

Bobyleva V, Kneer N, Bellei M, Battelli D, Lardy HA

Plain English
This study looked at how dehydroepiandrosterone (DHEA) affects fat burning in rats. The researchers found that DHEA treatment led to less weight gain without changing how much the rats ate. Specifically, certain enzymes related to energy production and heat creation were more active after DHEA treatment, suggesting that this hormone helps the body burn more energy as heat instead of storing it as fat. Who this helps: This research helps patients looking for weight management solutions and doctors seeking effective treatments for obesity.

PubMed

Comparative studies of effects of dehydroepiandrosterone on rat and chicken liver.

1993

Comparative biochemistry and physiology. B, Comparative biochemistry

Bobyleva V, Kneer N, Bellei M, Battelli D, Muscatello U +1 more

Plain English
This study looked at how a hormone called dehydroepiandrosterone (DHEA) affects the livers of rats and chickens and why it seems to slow down weight gain in these animals. Researchers found that while chickens didn’t gain weight after taking DHEA for 7-10 days, their liver functions changed, specifically with increased respiration and altered enzyme activities. For rats, changes happened in a different way, highlighting that the hormone affects different species uniquely. Who this helps: This research benefits scientists and veterinarians studying animal growth and hormone treatments.

PubMed

[The protective effect of cyclosporine A, carnitine, and Mg(2+) with ADP during calcium(2+)-dependent permeabilization of mitochondria by fatty acids and activation of NADH oxidation by an external pathway].

1993

Biokhimiia (Moscow, Russia)

Starkov AA, Markova OV, Mokhova EN, Arrigoni-Martelli E, Battelli D +1 more

Plain English
This study looked at how certain compounds—cyclosporine A, magnesium with ADP, and L-carnitine—affect liver mitochondria when they are exposed to certain fatty acids. The researchers found that these compounds can effectively prevent the breakdown of energy production in mitochondria caused by calcium ions, with cyclosporine A showing a significant effect when combined with magnesium and ADP. This discovery is important because it offers insights into how we might protect cells from damage that can happen when energy production goes wrong, especially in conditions related to metabolic issues. Who this helps: This benefits patients with liver diseases and metabolic disorders.

PubMed

Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone.

1992

The Journal of nutrition

Bellei M, Battelli D, Fornieri C, Mori G, Muscatello U +2 more

Plain English
This study looked at how a chemical called dehydroepiandrosterone affects the liver of rats over short (7 days) and long (100 days) periods. After just a week, the liver cells grew larger and had more energy-producing structures, but after 100 days, the liver cells returned to normal, although some energy structures showed signs of damage. These findings matter because they provide insights into how this chemical influences liver health and energy metabolism. Who this helps: This helps researchers and healthcare professionals understand liver responses to hormonal treatments.

PubMed

Interaction of carnitine with mitochondrial cardiolipin.

1992

Biochimica et biophysica acta

Battelli D, Bellei M, Arrigoni-Martelli E, Muscatello U, Bobyleva V

Plain English
This study looked at how L-carnitine, a molecule that helps transport energy in cells, interacts with a membrane component called cardiolipin in the mitochondria of rat livers. Researchers found that a drug called adriamycin blocks the positive effects of carnitine on cell respiration, and when cardiolipin is present, it can reverse this blocking effect. These findings are important because they suggest that the way carnitine influences cell energy might depend on its interaction with cardiolipin, which could have implications for understanding treatments for conditions related to mitochondrial function. Who this helps: This helps patients with mitochondrial disorders and doctors who treat them.

PubMed

Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine.

1989

Biochemical and biophysical research communications

Bellei M, Battelli D, Guarriero DM, Muscatello U, DiLisa F +2 more

Plain English
This study looked at how ammonium salts affect tiny energy factories in liver cells called mitochondria. Researchers found that these salts lower the energy production by causing swelling in the mitochondria. However, adding L-carnitine helps prevent this swelling and keeps the mitochondria healthy. Who this helps: This benefits patients with liver conditions and those looking for treatments to protect liver function.

PubMed

Sources of intramitochondrial malate.

1989

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Bobyleva-Guarriero V, Battelli D, Bellei M, Lardy HA

Plain English
This study looked at how certain hormones and exercise affect the levels of a substance called malate in the mitochondria of rat livers. Researchers found that after giving rats hormones or making them exercise, the amount of malate in their liver mitochondria increased, especially when they were injected with certain amino acids. Specifically, hormones like glucagon and cortisol raised malate levels in the liver mitochondria, regardless of whether the rats had their adrenal glands removed or not. Who this helps: This helps researchers and doctors understand energy production in the liver, which can improve treatment for metabolic disorders.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.